![Humens logo](/sites/default/files/styles/etudes_thumbs/public/2024-02/logo_Humens.jpg?itok=Sr1RxrBZ)
Stories
Mid-large buyout
Clinical-stage biotechnology company developing therapeutic vaccines for the treatment of cancer
Healthcare - Kurma Partners
StatusIn portfolio
Investment date03/2021
SectorHealthcare
LocationEurope
Leading producer of bioethanol in Spain and France
Asset-based Finance
StatusIn portfolio
Investment date04/2021
SectorAutres
LocationEurope
Driving License edtech platform
Venture - Digital
StatusIn portfolio
Investment date04/2021
SectorTech-enabled
LocationEurope
Portfolio of 8 hotels located in France
Real Estate
StatusIn portfolio
Investment date05/2021
SectorAutres
LocationEurope
Air quality monitoring software
Venture - Smart city
StatusIn portfolio
Investment date05/2021
SectorTech-enabled
LocationEurope
Cybersecurity expert
Small-mid buyout
StatusIn portfolio
Investment date05/2021
SectorTech-enabled
LocationEurope
Eurazeo Investment Manager (EIM) and Eurazeo Mid Cap (EMC) are merging to form Eurazeo Global Investor (EGI)